HEB Hemispherx Biopharma Inc New

1.80
0.00 (0.0%)
Sep 21 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Hemispherx Biopharma Financial Summary

The current HEB market cap is 87.61M. The company's latest EPS is -0.4 and P/E is -4.50.

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 367k140k163k135k141k
Operating Income -11.5M-12.44M-15.02M-17.06M-19.92M
Net Income -9.81M-9.53M-14.4M-19.13M-19.45M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 13.85M20.22M64.58M57.7M40.49M
Total Liabilities 8.67M7.31M3.29M820k2.02M
Total Equity 5.17M12.91M61.29M56.88M38.47M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -10.64M-9.07M-10.37M-13.97M-16.11M
Investing 92k-6.15M-9.16M-631k10.99M
Financing 9.44M16.39M56.56M8.19M80k
Market Cap 87.61M
Price to Earnings Ratio -4.50
Price to Sales Ratio 0
Price to Cash Ratio 3.21
Price to Book Ratio 2.28
Dividend Yield -

Share Statistics

Shares Outstanding 48.67M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.2 (10.15%)

Company Info

Company Name Hemispherx Biopharma Inc New
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.aimimmuno.com
Industry biological pds,ex diagnstics (2836)